Amelioration of inflammatory myopathies by glucagon‐like peptide‐1 receptor agonist via suppressing muscle fibre necroptosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amelioration of inflammatory myopathies by glucagon‐like peptide‐1 receptor agonist via suppressing muscle fibre necroptosis
Authors
Keywords
-
Journal
Journal of Cachexia Sarcopenia and Muscle
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-07-01
DOI
10.1002/jcsm.13025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies
- (2022) Mari Kamiya et al. Nature Communications
- Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle : update 2021
- (2021) Stephan Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway
- (2020) Xue Han et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nonimmune mechanisms in idiopathic inflammatory myopathies
- (2020) Marta Loredo Martinez et al. CURRENT OPINION IN RHEUMATOLOGY
- Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
- (2019) Yeonhee Hong et al. Journal of Cachexia Sarcopenia and Muscle
- A new in vitro model of polymyositis reveals CD8+ T cell invasion into muscle cells and its cytotoxic role
- (2019) Mari Kamiya et al. RHEUMATOLOGY
- The protective effects of lixisenatide against inflammatory response in human rheumatoid arthritis fibroblast-like synoviocytes
- (2019) Xingye Du et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents
- (2019) Anagha Ashok Gurjar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- AMP-activated protein kinase protects against necroptosis via regulation of Keap1-PGAM5 complex
- (2018) Yi-Shu Wang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome
- (2017) Yingying Zhang et al. Nature Communications
- 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
- (2017) Ingrid E. Lundberg et al. Arthritis & Rheumatology
- One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer
- (2017) Kelli M. Luginbuhl et al. Nature Biomedical Engineering
- The Cardiovascular Biology of Glucagon-like Peptide-1
- (2016) Daniel J. Drucker Cell Metabolism
- Sarcopenia in Elderly Diabetic Patients: Role of Dipeptidyl Peptidase 4 Inhibitors
- (2016) Maria Rosaria Rizzo et al. Journal of the American Medical Directors Association
- Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice
- (2014) Si GOU et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells
- (2014) Zhu Li et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a
- (2013) Craig W. Younce et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis
- (2012) Mei Zong et al. ANNALS OF THE RHEUMATIC DISEASES
- Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation
- (2012) Daisuke Shiraishi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Mitochondrial Phosphatase PGAM5 Functions at the Convergence Point of Multiple Necrotic Death Pathways
- (2012) Zhigao Wang et al. CELL
- Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats
- (2011) Wei Jing Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
- (2011) D. J. Drucker et al. DIABETOLOGIA
- Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis
- (2011) A. E. Hogan et al. DIABETOLOGIA
- Age-related changes in skeletal muscle reactive oxygen species generation and adaptive responses to reactive oxygen species
- (2011) Malcolm J. Jackson et al. JOURNAL OF PHYSIOLOGY-LONDON
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
- (2009) M. H. Noyan-Ashraf et al. DIABETES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started